FAP imaging in rare cancer entities: first clinical experience in a broad spectrum of malignancies

68 Ga-FAPI (fibroblast activation protein inhibitor) is a rapidly evolving and highly promising radiotracer for PET/CT imaging, presenting excellent results in a variety of tumor entities, particularly in epithelial carcinomas. This retrospective analysis sought to evaluate the potential and impact...

Full description

Bibliographic Details

Main Authors:	Dendl, Katharina (Author) , Finck, Rebecca (Author) , Giesel, Frederik L. (Author) , Kratochwil, Clemens (Author) , Lindner, Thomas (Author) , Mier, Walter (Author) , Cardinale, Jens (Author) , Kesch, Claudia (Author) , Röhrich, Manuel (Author) , Rathke, Hendrik (Author) , Gampp, Heike (Author) , Ristau, Jonas (Author) , Adeberg, Sebastian (Author) , Jäger, Dirk (Author) , Debus, Jürgen (Author) , Haberkorn, Uwe (Author) , Körber, Stefan A. (Author)
Format:	Article (Journal)
Language:	English
Published:	2022
In:	European journal of nuclear medicine and molecular imaging Year: 2022, Volume: 49, Issue: 2, Pages: 721-731
ISSN:	1619-7089
DOI:	10.1007/s00259-021-05488-9
Online Access:	Resolving-System, kostenfrei, Volltext: https://doi.org/10.1007/s00259-021-05488-9
Author Notes:	K. Dendl, R. Finck, F. L. Giesel, C. Kratochwil, T. Lindner, W. Mier, J. Cardinale, C. Kesch, M. Röhrich, H. Rathke, H. Gampp, J. Ristau, S. Adeberg, D. Jäger, J. Debus, U. Haberkorn, S. A. Koerber